FBTCX vs. GBTC

In the year-to-date period, FBTCX achieves a -7.64% return, which is significantly lower than GBTC's 11.42% return. Over the past 10 years, FBTCX has underperformed GBTC with an annualized return of 2.57%, while GBTC has yielded a comparatively higher 76.27% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Biotechnology Fund Class C (FBTCX) and Grayscale Bitcoin Trust (BTC) (GBTC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current FBTCX Sharpe Ratio is -0.27, which is lower than the GBTC Sharpe Ratio of 0.98. The chart below compares the historical Sharpe Ratios of FBTCX and GBTC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

FBTCX's dividend yield for the trailing twelve months is around 7.40%, while GBTC has not paid dividends to shareholders.

The maximum FBTCX drawdown since its inception was -61.27%, smaller than the maximum GBTC drawdown of -89.91%. Use the drawdown chart below to compare losses from any high point for FBTCX and GBTC.

Fidelity Advisor Biotechnology Fund Class C (FBTCX) has a higher volatility of 9.98% compared to Grayscale Bitcoin Trust (BTC) (GBTC) at 9.39%. This indicates that FBTCX's price experiences larger fluctuations and is considered to be riskier than GBTC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.